Quantisnow Logo
Dashboard

Carenet Health Acquiring Health Dialog, Enhancing Clinical Team and Advancing Insights-Driven Platform Dedicated to the Business of Healthcare

$RAD
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Get the next $RAD alert in real time by email

Expanded personalized population health capabilities support better health journeys for patients

Carenet Health, a trusted partner in helping organizations simplify and power the business of healthcare, is excited to announce it is acquiring Health Dialog, a worldwide leader in delivering clinical decision support offerings.

This acquisition enables Carenet to leverage its combined platform, analytics and clinicians to deliver greater efficiency and outcomes-based financial performance for clients.

Health Dialog provides personalized population health services to health plans, providers, employers and pharmaceutical manufacturers. Carenet is acquiring all assets of Health Dialog from Rite Aid, including a world-class clinical staff, vital population health programs and robust data analytics and modeling capabilities with proven ROI.

"Health Dialog has long been renowned for the quality and commitment of its team as well as the depth of its analytics and insights," said John Erwin, Carenet chief executive officer. "Centering on the doctor and patient relationship helps ensure more informed choices and better health outcomes. We look forward to welcoming the incredible Health Dialog team of clinical experts to the Carenet family."

For more than 20 years, Health Dialog has focused on establishing effective, research-driven interactions between patients and clinical experts to achieve better care all while containing costs for healthcare organizations. Both Health Dialog and Carenet maintain more than 90% customer satisfaction rates.

"The commitment Health Dialog has to improving care through intelligent, data-driven insights and empathy aligns perfectly with our Carenet values," said Mick Mazour, Carenet president. "Integrating Health Dialog's offerings into the full Carenet portfolio will lead to advanced business outcomes for our clients and better care for their members, patients and customers."

Both Carenet and Health Dialog hold accreditations from the National Committee for Quality Assurance (NCQA), URAC and HITRUST.

About Carenet Health

Carenet Health helps organizations simplify and power the business of healthcare through people, technology and industry-leading insights. With hundreds of licensed clinicians and care navigators throughout North America, Carenet supports more than 600 premier health plans, providers and health systems in reimagining population health and putting the consumer and patient at the center of health care decisions. Through personalization, innovation and consultation, Carenet fuels growth seamlessly for their clients while improving care – supporting healthcare organizations as they grow and evolve their offerings. Learn more at www.carenethealth.com.

About Health Dialog

Health Dialog Services Corporation is a leading provider of population health management solutions. As a wholly owned subsidiary of Rite Aid Corporation (NYSE:RAD), the company works with the nation's largest health plans, employers and providers to improve the health and wellness of their members, employees, patients and customers while reducing costs and improving performance in key quality measures, such as NCQA's HEDIS and CMS' Stars ratings. Health Dialog's unique capabilities include data analytics, a multi-channel coaching platform, shared decision-making tools and a 24/7 nurse line. For more information, visit www.healthdialog.com.

Get the next $RAD alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RAD

DatePrice TargetRatingAnalyst
4/7/2022$16.00 → $1.00Hold → Sell
Deutsche Bank
6/25/2021$21.00 → $12.00Neutral → Underweight
JP Morgan
More analyst ratings

$RAD
 Press Releases

Fastest customizable press release news feed in the world

See more

  • Carenet Health Acquiring Health Dialog, Enhancing Clinical Team and Advancing Insights-Driven Platform Dedicated to the Business of Healthcare

    Expanded personalized population health capabilities support better health journeys for patients Carenet Health, a trusted partner in helping organizations simplify and power the business of healthcare, is excited to announce it is acquiring Health Dialog, a worldwide leader in delivering clinical decision support offerings. This acquisition enables Carenet to leverage its combined platform, analytics and clinicians to deliver greater efficiency and outcomes-based financial performance for clients. Health Dialog provides personalized population health services to health plans, providers, employers and pharmaceutical manufacturers. Carenet is acquiring all assets of Health Dialog from

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations

    Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC:RADCQ) ("Rite Aid" or the "Company") today announced that it has received approvals from the U.S. Bankruptcy Court for the District of New Jersey for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on October 15, 2023. The Court granted interim approval to access up to $3.45 billion in debtor-in-possession financing from certain of its lenders. This financing is expected to provide sufficient liquidity to support the Company th

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

    Stein Succeeds Elizabeth "Busy" Burr Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth ("Busy") Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company's Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Stein has particular expertise in supporting companies that are driving meaningful business tran

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$RAD
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$RAD
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$RAD
 SEC Filings

See more

$RAD
 Leadership Updates

Live Leadership Updates

See more

  • Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

    Stein Succeeds Elizabeth "Busy" Burr Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth ("Busy") Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company's Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Stein has particular expertise in supporting companies that are driving meaningful business tran

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success

    Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment for $3.45 Billion in New Financing to Support Business Operations Continuing to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced it has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the Co

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$RAD
 Financials

Live finance-specific insights

See more

  • Rite Aid Corporation Reports Fiscal 2024 First Quarter Results

    Revenues of $5.7 Billion, Compared to Prior Year Revenues of $6.0 Billion Retail Comparable Same Store Prescriptions Increased 4.7 Percent – Comparable Same Store Prescriptions, Excluding COVID Impact, Increased 7.4 Percent Net Loss of $306.7 Million Compared to Prior Year Net Loss of $110.2 Million – Increase Largely Attributable to a Goodwill Impairment Charge at Elixir Adjusted EBITDA of $91.7 Million, Compared to Prior Year Adjusted EBITDA of $100.1 Million Updates Fiscal 2024 Outlook Rite Aid Corporation (NYSE:RAD) today reported operating results for its first fiscal quarter ended June 3, 2023. "Our first quarter results were driven by strong script growth, solid ph

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • Rite Aid to Release First Quarter Results on June 29

    Rite Aid Corporation (NYSE:RAD) will release financial results for its Fiscal 2024 First Quarter, which ended June 3, 2023, on Thursday, June 29, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, June 29, 2023, through 11:59 p.m. ET on July 29, 2023. To access the replay of the call, please dial (800) 770-2030 or (647) 362-9199 and enter the seven-digit reservation number 9029129. The webcast replay of the call will also be available at https://investors.riteaid.com starting at 12 p.m. ET Thursda

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • Rite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook

    Fourth Quarter Highlights: Revenues of $6.1 billion, Comparable to Prior Year Retail Comparable Same Store Prescriptions Increased 5.2 Percent – Comparable Same Store Prescriptions, Excluding COVID Impacts, Increased 9.7 Percent Net Loss per Share of $4.39, Compared to Prior Year Net Loss per Share of $7.18 Adjusted EBITDA of $128.6 million, Compared to the Prior Year Adjusted EBITDA of $106.1 million Completed Tender Offer for $165 million of our 2025 notes – Reducing Amount Outstanding to $320 million From $600 million at Beginning of Fiscal 2022 Full Year Highlights: Revenues of $24.1 billion, Compared to Prior Year Revenues of $24.6 billion Retail Comparable Same

    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$RAD
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more